We recently added another molecular evidence supporting the convergence of pathogenesis leading to neurodegenerative and metabolic diseases by elucidating the involvement of PARL-PINK1-Parkin system in adipogenesis [17]. This evidence concerns the gene PRKN and metabolic disease.